Q3 2021 Biocon Ltd Earnings Call Transcript
Ladies and gentlemen, good day, and welcome to the Biocon Limited Q3 FY '21 Earnings Conference Call. (Operator Instructions) Please note that this conference is being recorded.
I would now like to hand the conference over to Mr. Ankit Gupta from Biocon Investor Relations. Thank you, and over to you, sir.
Thank you, Janice. Good morning, everyone. I'm Ankit from Biocon Investor Relations team, and I welcome you to Biocon's earnings call for Q3 FY '21. To discuss the company's business performance and outlook, we have today with us the Biocon leadership team comprising Dr. Kiran Mazumdar Shaw, our CMD; and other colleagues from the senior management team, both from Biocon Biologics and Biocon.
I would like to take this opportunity to remind everyone about safe harbor statement. Today's discussion may be forward-looking in nature based on management's current beliefs and expectations. It must be viewed in concurrence with the risks that our business faces that could cause our future results, performance or achievements to differ
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |